Author: Biotech Express

Union Minister of State (Independent Charge) for Science and Technology, Dr Jitendra Singh chaired a joint meeting of senior officials from all Science Ministries and Departments to review the progress of ongoing projects and budget utilization, emphasising synergy and breaking down silos to enhance coordination and efficiency. Dr. Jitendra Singh emphasized the need for timely and optimal use of budgetary resources, urging officials from key departments, including the Department of Science & Technology, Department of Biotechnology, ISRO, CSIR/DSIR, Ministry of Earth Sciences, Department of Space and the Department of Atomic Energy to accelerate their work on several projects including ANRF…

Two day symposium on ‘Strategies to Combat Economically Important Porcine & Poultry viruses in India’ which was organized by NIAB in M K Bhan auditorium was concluded successfully on 4th October 2024. The event gathered renowned animal biologists from the country and discussed various aspects related to animal husbandry and particular to animal viruses- types and hosts, challenges in combating them, vaccine production, regulatory challenges, surveillance measure, and many other interrelated points. The symposium was inaugurated by Dr. G. Taru Sharma, Director, NIAB in MK Bhan Auditorium, NIAB. During the inaugural address Dr Taru explained how and why this symposium…

The department of medical genetics at the Nizam’s Institute of Medical Sciences (NIMS) and the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad have reported the discovery of a new genetic disease termed as ‘lethal serpinopathy’. The study highlighting this discovery was published in the September 2024 issue of the journal ‘Clinical Genetics.’ The researchers said that the new genetic disease was seen in a family with recurring pregnancy issues. The teams from NIMS and CDFD worked with a family whose babies suffered from fluid accumulation in their body cavities and organs, leading to premature death. The study, led…

Recently, this month a great gathering of Biotech Startups at “Global Bio India” was seen in Pragati Maidan, New Delhi which let us feel the tides that are building up in Indian biotech sector. Now not only scientists but students can also apply for grants and avail the Government facilities to bring their idea or innovation to industry, unlike before when funds were disbursed to govt scientists and affiliates. BIRAC and DBT head, Dr Rajesh Gokhale launched BioE3 in Global Bio India 2024.BioE3, one of the two major initiatives were approved by the Union Cabinet in August 2024—the other one…

Latest Book titled ‘Nutrition Interventions for Disease Prevention” recently released by Shraddha Vyas. The book provides a comprehensive exploration of the crucial role nutrition plays in disease prevention, offering readers a wealth of knowledge to help them lead healthier lives. The first chapter, *Nutritional Intervention*, introduces the concept of *Applied Nutrition*, offering an overview that sets the stage for understanding the importance of diet planning and meal management. This section guides readers in making informed decisions about their daily food intake and provides dietary modifications tailored to specific health issues, offering practical strategies for managing and improving overall health. Detailed…

The scheme has three broad components: • Biotechnology R&D; • Industrial & Entrepreneurship Development (I&ED) • Biomanufacturing and Biofoundry The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, today approved continuation of the two umbrella schemes of Department of Biotechnology (DBT), merged as one scheme-‘Biotechnology Research Innovation and Entrepreneurship Development (Bio- RIDE)’ with a new component namely Biomanufacturing and Biofoundry. The proposed outlay for the implementation of the unified scheme ‘Bio-RIDE’ is Rs.9197 crore during the 15th finance Commission period from 2021-22 to 2025-26. Bio-RIDE scheme is designed to foster innovation, promote bio-entrepreneurship, and strengthen India’s position as…

The Federation of Asian Biotech Associations (FABA) in collaboration with University of Hyderabad, Institute of Eminence and Science Gurus successfully concluded its Innovation Summit 2024, a landmark series of events that brought together global experts, innovators, and investors in the life sciences sector. The summit, held from 3rd to 18th August 2024, comprised three major components: the Drug Discovery & Development Workshop, the Whale Tank startup pitch event, and the Life Sciences Innovation Cluster Meet. Drug Discovery & Development Workshop: Initiating the summit was the highly anticipated Drug Discovery & Development Workshop, held online from 3rd to 16th August. The…

Panacea Biotec share price touched its 52-week high of Rs 349.79 per share on the NSE after the company announced that it has entered into a settlement agreement with Sanofi Healthcare India over patent dispute. Panacea Biotec and Sanofi Healthcare India have entered into the settlement agreement on dispute over a patent infringement for hexavalent vaccine. The company in an exchange filing, said “the parties have reached a settlement agreement, and pursuant to the joint application filed by the Parties, the said suit has been disposed of by the Hon’ble Delhi High Court on September 13, 2024, in terms of…

BlueKraft Digital Foundation marked Prime Minister Narendra Modi’s 74th birthday celebrations on September 17 with the launch of its new publishing and knowledge centre and the announcement of the Viksit Bharat Fellowship. The initiative is aimed at empowering emerging and seasoned professionals, academics and experts both within India and globally to contribute to a rich and meaningful narrative about the nation. The Viksit Bharat Fellowship offers 25 fellowships in three distinct tiers — BlueKraft Associate Fellowship, BlueKraft Senior Fellowship and BlueKraft Distinguished Fellowship. Each tier comes with its own stipend structure. Associate Fellows will receive Rs 75,000 per month, Senior…

Global Bio India – flagship event of DBT and BIRAC took place during 11-14th September, 2024 in Pragati Maidan, New Delhi. The event was a great success because it is probably the first time when any event of the Biotech sector witnessed this huge crowd. In this edition, GBI 2024 theme has been ‘Biotech Innovation’ and ‘Bio-manufacturing’ and its impact on the Bioeconomy. It also witnessed the launch of the BioE3 policy recently approved by the government. BIOe3 stands for Biotechnology for— economic growth, environment sustainability and employment generation. Unlike many other events of Biotech the focus here was on startups…